Studies have demonstrated that chronic administration of AOD-9604 leads to adaptive changes in adipose tissue, including increased expression of beta-3 adrenergic receptors and enhanced sensitivity to lipolytic signals
Brand-name Wegovy carries a list price of roughly $1,349 per month, though manufacturer savings programs can reduce that significantly for qualifying patients
It brings in new risks, such as: Germs in your medicine The medicine is not working at all Unknown long-term problems These new risks can cancel out the notion that being small makes it safer
Bohn, M
Increase fibre intake Dietary fibre, particularly from fruits, vegetables, and whole grains, slows digestion and promotes the release of GLP-1
No completed, peer-reviewed human efficacy or long-term safety trial exists as of 2026